JP2024523453A5 - - Google Patents
Info
- Publication number
- JP2024523453A5 JP2024523453A5 JP2023578817A JP2023578817A JP2024523453A5 JP 2024523453 A5 JP2024523453 A5 JP 2024523453A5 JP 2023578817 A JP2023578817 A JP 2023578817A JP 2023578817 A JP2023578817 A JP 2023578817A JP 2024523453 A5 JP2024523453 A5 JP 2024523453A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyldiyl
- peg
- pep
- heterocyclyldiyl
- immunocomplex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163215100P | 2021-06-25 | 2021-06-25 | |
| US63/215,100 | 2021-06-25 | ||
| PCT/US2022/034865 WO2022272039A1 (en) | 2021-06-25 | 2022-06-24 | Bis-benzimidazole sting agonist immunoconjugates, and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024523453A JP2024523453A (ja) | 2024-06-28 |
| JP2024523453A5 true JP2024523453A5 (cg-RX-API-DMAC7.html) | 2025-06-16 |
Family
ID=82850579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023578817A Pending JP2024523453A (ja) | 2021-06-25 | 2022-06-24 | ビス-ベンゾイミダゾールstingアゴニスト免疫複合体及びその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250057967A2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4359007A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024523453A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240027018A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117794583A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022300383A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3222082A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL309278A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022272039A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024137619A1 (en) * | 2022-12-20 | 2024-06-27 | Bolt Biotherapeutics, Inc. | Anti-claudin, bis-benzimid azole sting agonist immunoconjugates, and uses thereof |
| WO2024174863A1 (zh) * | 2023-02-22 | 2024-08-29 | 深圳众格生物科技有限公司 | Sting激动剂及其制备方法和医药用途 |
| AU2024315750A1 (en) | 2023-07-31 | 2026-03-05 | Sutro Biopharma, Inc. | Sting agonist compounds and conjugates |
| CN117771206B (zh) * | 2023-08-02 | 2024-05-28 | 首都医科大学附属北京儿童医院 | Sting激动剂仿生纳米递送系统及其制备方法和应用 |
| WO2025233679A1 (en) * | 2024-05-08 | 2025-11-13 | Ligachem Biosciences Inc. | Compositions and methods related to a combination therapy of sting agonists and antibody drug conjugates |
| TW202604486A (zh) * | 2024-05-08 | 2026-02-01 | 韓商瑞嘉化學生物科學股份有限公司 | 與sting促效劑及免疫檢查點抑制劑之組合療法相關之組合物及方法 |
| TW202613130A (zh) | 2024-05-30 | 2026-04-01 | 日商安斯泰來製藥股份有限公司 | Sting促效劑免疫刺激性抗體藥物結合物 |
| WO2026055185A1 (en) * | 2024-09-04 | 2026-03-12 | Bolt Biotherapeutics, Inc. | Sting agonist immunoconjugates and uses thereof |
| WO2026078593A1 (en) | 2024-10-08 | 2026-04-16 | Sun Pharma Advanced Research Company Limited | Sting agonists and antibody drug conjugates thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201900628RA (en) * | 2016-04-07 | 2019-02-27 | Glaxosmithkline Ip Dev Ltd | Heterocyclic amides useful as protein modulators |
| AR113224A1 (es) * | 2017-04-28 | 2020-02-19 | Novartis Ag | Conjugados de anticuerpo que comprenden un agonista de sting |
| AU2018344902B2 (en) * | 2017-10-05 | 2021-06-03 | Glaxosmithkline Intellectual Property Development Limited | Modulators of stimulator of interferon genes (STING) useful in treating HIV |
| US11377440B2 (en) * | 2017-10-05 | 2022-07-05 | Glaxosmithkline Intellectual Property Development Limited | Modulators of stimulator of interferon genes (STING) |
| CN118846110A (zh) * | 2018-09-06 | 2024-10-29 | 第一三共株式会社 | 抗体药物偶联物 |
| CN113348181A (zh) * | 2018-10-31 | 2021-09-03 | 诺华股份有限公司 | 包含sting激动剂的dc-sign抗体缀合物 |
| JP2022529183A (ja) * | 2019-04-17 | 2022-06-17 | アヴィディア テクノロジーズ, インコーポレイテッド | リガンド提示および/または薬物送達のためのスターポリマーを製造する組成物および方法 |
| TWI925817B (zh) * | 2019-05-10 | 2026-05-21 | 日商武田藥品工業股份有限公司 | 抗體藥物結合物 |
| JP2022537158A (ja) * | 2019-06-13 | 2022-08-24 | ボルト バイオセラピューティクス、インコーポレーテッド | アミノベンズアゼピン化合物、イムノコンジュゲート、及びそれらの使用 |
| US11033635B2 (en) * | 2019-07-19 | 2021-06-15 | Immunesensor Therapeutics, Inc. | Antibody-STING agonist conjugates and their use in immunotherapy |
| CN116196435B (zh) * | 2020-04-02 | 2025-12-02 | 梅尔莎纳医疗公司 | 包含sting激动剂的抗体药物缀合物 |
-
2022
- 2022-06-24 US US18/573,094 patent/US20250057967A2/en active Pending
- 2022-06-24 WO PCT/US2022/034865 patent/WO2022272039A1/en not_active Ceased
- 2022-06-24 JP JP2023578817A patent/JP2024523453A/ja active Pending
- 2022-06-24 CA CA3222082A patent/CA3222082A1/en active Pending
- 2022-06-24 CN CN202280053551.7A patent/CN117794583A/zh active Pending
- 2022-06-24 EP EP22753804.8A patent/EP4359007A1/en not_active Withdrawn
- 2022-06-24 AU AU2022300383A patent/AU2022300383A1/en not_active Abandoned
- 2022-06-24 IL IL309278A patent/IL309278A/en unknown
- 2022-06-24 KR KR1020247002332A patent/KR20240027018A/ko active Pending